Cellebrite Form 144: 31,728 RSUs Vest on 05/15/2026

Cellebrite DI Ltd. submitted a Form 144 notice regarding proposed sales of Ordinary shares arising from vested restricted share units.

Rhea-AI Filing Summary

Cellebrite DI Ltd. submitted a Form 144 notice regarding proposed sales of Ordinary shares arising from vested restricted share units. The filing shows 31,728 Ordinary shares vested under an S-8 registered plan on 05/15/2026. The filing also reports recent sales by Marcus Jewell of 4,613 shares on 02/18/2026 for $65,221.36 and 383 shares on 05/12/2026 for $4,983.33.

Insights

Securities Compliance Analyst

Form 144 documents proposed resale of shares from vested RSUs and lists recent small-volume sales by an affiliate.

The filing records 31,728 Ordinary shares that vested under an S-8 registered plan on 05/15/2026, indicating the source of the shares available for resale. The filing also itemizes prior sales by Marcus Jewell on 02/18/2026 (4,613 shares, $65,221.36) and 05/12/2026 (383 shares, $4,983.33).

Timing and distribution methods for any resale are not described in the excerpt; subsequent filings or broker reports would show actual transactions. Cash‑flow treatment and purchaser identity are not stated in the provided excerpt.

Key Figures

Vested RSUs: 31,728 shares Sale on 02/18/2026: 4,613 shares Sale on 05/12/2026: 383 shares +1 more

4 metrics

Vested RSUs 31,728 shares Vested under an Issuer S-8 Registered Plan on <date>05/15/2026</date>

Sale on 02/18/2026 4,613 shares Proceeds <money>$65,221.36</money>

Sale on 05/12/2026 383 shares Proceeds <money>$4,983.33</money>

Par value NIS 0.00001 Ordinary shares par value stated in the excerpt

Key Terms

Restricted Share Units Vested, S-8 Registered Plan, Ordinary shares, par value NIS 0.00001

3 terms

Restricted Share Units Vested financial

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

S-8 Registered Plan regulatory

"Issuer S-8 Registered Plan"

Ordinary shares, par value NIS 0.00001 financial

"Ordinary shares, par value NIS 0.00001"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Cellebrite's Form 144 (CLBT) disclose about the shares available for sale?

It discloses 31,728 Ordinary shares vested under an S-8 registered plan on 05/15/2026. These vested restricted share units are identified as the source of shares noted for potential resale.

Who sold shares recently according to the Form 144 for CLBT?

The filing lists sales by Marcus Jewell: 4,613 shares sold on 02/18/2026 for $65,221.36 and 383 shares sold on 05/12/2026 for $4,983.33. These are disclosed as recent dispositions.

Are the proceeds from the reported transactions specified in the CLBT Form 144?

Yes. The excerpt shows proceeds of $65,221.36 for the 02/18/2026 sale (4,613 shares) and $4,983.33 for the 05/12/2026 sale (383 shares).

Does the Form 144 excerpt state how the vested RSUs will be sold?

No. The provided excerpt identifies the vested RSUs (31,728 shares) but does not specify the planned sale method, timing, or broker distribution details in the text shown.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:13 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001875661
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cellebrite DI Ltd.
SEC File Number	001-40772
Address of Issuer	94 SHLOMO SHMELZER ROAD PETAH TIKVA ISRAEL 4970602
Phone	972-73-394-8000
Name of Person for Whose Account the Securities are To Be Sold	MARCUS JEWELL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	12658	164300.84	249998743	05/18/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	05/15/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	Cellebrite DI Ltd.			31728	05/15/2026	Employee compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marcus Jewell 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	02/18/2026	4613	65221.36
Marcus Jewell 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Ordinary shares, par value NIS 0.00001	05/12/2026	383	4983.33

144: Remarks and Signature

Remarks	The reporting person sold the securities reported herein on 05/18/2026 pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purposes of satisfying income tax liabilities incurred upon vesting of restricted share unit awards only.
Date of Notice	05/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Marcus Jewell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)